On this occasion, our partner Radiomedix, Inc. , was selected to present an update of our joint research program. This talk untitled “Glioblastoma and Pancreatic Adenocarcinoma - Versatile radiolabeled probe targeting Low Density Lipoprotein Receptors (LDLR)” will be given Sunday, September 10th between 4:55 PM and 5:05 PM at the Hall E2 by Izabela Tworowska.

Come and take the opportunity to meet and discuss with Vect-Horus on September 9-13, 2023 in Vienna!
Our #Oncology team, Cedric Malicet and Jonathan Nowak, will be delighted to exchange on our VECTRans® Platform Technology and its applications in Nuclear Medicine Imaging!

More about the conference: https://eanm23.eanm.org/

#EANM23 #nuclearmedicine #drugdelivery